Astria Therapeutics logo

Astria Therapeutics Share Price (NASDAQ: ATXS)

$6.17

-0.36

(-5.51%)

Last updated on

Check the interactive Astria Therapeutics Stock chart to analyse performance

Astria Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.12
    Today's High:$6.59

    Day's Volatility :7.06%

  • 52 Weeks Low:$3.56
    52 Weeks High:$12.92

    52 Weeks Volatility :72.48%

Astria Therapeutics Stock Returns

PeriodAstria Therapeutics IncIndex (Russel 2000)
3 Months
29.18%
0.0%
6 Months
1.23%
0.0%
1 Year
-46.12%
0.0%
3 Years
-28.86%
-4.1%

Astria Therapeutics Inc Key Stats

Check Astria Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.53
Open
$6.585
Today's High
$6.585
Today's Low
$6.12
Market Capitalization
$368.5M
Today's Volume
$235.5K
52 Week High
$12.92
52 Week Low
$3.555
Revenue TTM
$0.0
EBITDA
$-32.4M
Earnings Per Share (EPS)
$-2.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-38.49%

Stock Returns calculator for Astria Therapeutics Stock including INR - Dollar returns

The Astria Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Astria Therapeutics investment value today

Current value as on today

₹59,124

Returns

₹40,876

(-40.88%)

Returns from Astria Therapeutics Stock

₹46,161 (-46.16%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Astria Therapeutics Stock

78%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Astria Therapeutics Stock from India on INDmoney has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Astria Therapeutics Inc

  • Name

    Holdings %

  • FMR Inc

    12.29%

  • Perceptive Advisors LLC

    11.49%

  • Vestal Point Capital LP

    7.41%

  • FCPM III SERVICES BV

    7.28%

  • BlackRock Inc

    6.78%

  • Fairmount Funds Management LLC

    6.30%

Analyst Recommendation on Astria Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Astria Therapeutics(by analysts ranked 0 to 5 stars)

Astria Therapeutics Share Price Target

What analysts predicted

Upside of 375.42%

Target:

$29.33

Current:

$6.17

Astria Therapeutics share price target is $29.33, a slight Upside of 375.42% compared to current price of $6.17 as per analysts' prediction.

Astria Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, ATXS stock has moved down by -9.1%
  • ATXS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 119.4%
  • ATXS vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 144.1%

Astria Therapeutics Technicals Summary

Sell

Neutral

Buy

Astria Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Astria Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Astria Therapeutics Inc logo
-5.87%
1.23%
-46.12%
-28.86%
-26.49%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Astria Therapeutics Inc

Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Organization
Astria Therapeutics
Employees
78
CEO
Ms. Jill C. Milne Ph.D.
Industry
Miscellaneous

Key Management of Astria Therapeutics Inc

NameTitle
Ms. Jill C. Milne Ph.D.
Co-Founder, CEO, President & Director
Mr. Benjamin S. Harshbarger J.D.
Chief Legal Officer
Dr. Christopher J. Morabito M.D.
Chief Medical Officer
Ms. Keri McGrail
Chief Human Resources Officer
Ms. Andrea L. Matthews
Chief Business Officer
Mr. Andrew A. Komjathy
Chief Commercial Officer
Mr. John Ruesch
Senior Vice President of Pharmaceutical Sciences & Technical Operations
Ms. Rafif Dagher
Senior VP and Head of Discovery, Nonclinical Development & Translational Research

Important FAQs about investing in ATXS Stock from India :

What is Astria Therapeutics share price today?

Astria Therapeutics share price today is $6.17 as on at the close of the market. Astria Therapeutics share today touched a day high of $6.59 and a low of $6.12.

What is the 52 week high and 52 week low for Astria Therapeutics share?

Astria Therapeutics share touched a 52 week high of $12.92 and a 52 week low of $3.56. Astria Therapeutics stock price today i.e. is closed at $6.17, lower by 52.24% versus the 52 week high.

How to invest in Astria Therapeutics Stock (ATXS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Astria Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Astria Therapeutics Shares that will get you 0.2431 shares as per Astria Therapeutics share price of $6.17 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Astria Therapeutics Stock (ATXS) from India?

Indian investors can start investing in Astria Therapeutics (ATXS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Astria Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Astria Therapeutics share’s latest price of $6.17 as on August 30, 2025 at 1:29 am IST, you will get 1.6207 shares of Astria Therapeutics. Learn more about fractional shares .

What are the returns that Astria Therapeutics has given to Indian investors in the last 5 years?

Astria Therapeutics stock has given -26.49% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?